deltatrials
Completed PHASE2/PHASE3 NCT00411463

Psychotherapy for Bipolar II Depression, Pilot Study, Phase II

Sponsor: National Alliance for Research on Schizophrenia and Depression

Updated 9 times since 2017 Last updated: Apr 21, 2017 Started: Dec 31, 2006 Primary completion: Sep 30, 2010 Completion: Sep 30, 2010

A PHASE2/PHASE3 clinical study on Bipolar II Disorder, this trial is completed. The trial is conducted by National Alliance for Research on Schizophrenia and Depression and has accumulated 9 data snapshots since 2006. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotCompleted~Feb 2017 – ~Jun 2017 · 4 months · monthly snapshotCompleted~Jun 2017 – ~Jun 2018 · 12 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Dec 2022 · 23 months · monthly snapshotCompleted~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshotCompleted~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 19 months · monthly snapshotCompleted

Change History

9 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed PHASE2/PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2/PHASE3

    Phase: PHASE2_PHASE3PHASE2/PHASE3

  3. Jan 2023 — Jul 2024 [monthly]

    Completed PHASE2_PHASE3

  4. Dec 2022 — Jan 2023 [monthly]

    Completed PHASE2_PHASE3

  5. Jan 2021 — Dec 2022 [monthly]

    Completed PHASE2_PHASE3

Show 4 earlier versions
  1. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE2_PHASE3

  2. Jun 2017 — Jun 2018 [monthly]

    Completed PHASE2_PHASE3

  3. Feb 2017 — Jun 2017 [monthly]

    Completed PHASE2_PHASE3

  4. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE2_PHASE3

    First recorded

Dec 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Alliance for Research on Schizophrenia and Depression
  • University of Pittsburgh
Data source: University of Pittsburgh

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations